2,264,198 Shares in Oscar Health, Inc. $OSCR Acquired by Nuveen LLC

Nuveen LLC acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,264,198 shares of the company's stock, valued at approximately $29,684,000. Nuveen LLC owned approximately 0.90% of Oscar Health at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after buying an additional 700,469 shares during the last quarter. Deerfield Management Company L.P. Series C lifted its holdings in shares of Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares during the period. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Gilder Gagnon Howe & Co. LLC lifted its holdings in shares of Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after buying an additional 2,151,256 shares during the period. Finally, BIT Capital GmbH lifted its stake in shares of Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares during the period. Institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

NYSE:OSCR traded up $0.8530 during trading hours on Friday, hitting $16.2730. The company's stock had a trading volume of 6,318,621 shares, compared to its average volume of 13,523,050. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The business's 50-day moving average is $16.06 and its two-hundred day moving average is $14.79. The company has a market capitalization of $4.21 billion, a PE ratio of -20.10 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm's quarterly revenue was up 29.0% compared to the same quarter last year. During the same period last year, the company posted $0.20 earnings per share. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Wells Fargo & Company lowered shares of Oscar Health from an "equal weight" rating to an "underweight" rating and cut their price target for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Piper Sandler cut their target price on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research note on Thursday, August 14th. Robert W. Baird reaffirmed a "neutral" rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Finally, Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Four analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.